000 01518 a2200445 4500
005 20250513135931.0
264 0 _c19980330
008 199803s 0 0 eng d
022 _a0091-2700
024 7 _a10.1002/j.1552-4604.1997.tb04272.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCallaghan, J T
245 0 0 _aOlanzapine: interaction study with imipramine.
_h[electronic resource]
260 _bJournal of clinical pharmacology
_cOct 1997
300 _a971-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdrenergic Uptake Inhibitors
_xadverse effects
650 0 4 _aAdult
650 0 4 _aAnalysis of Variance
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBenzodiazepines
650 0 4 _aCross-Over Studies
650 0 4 _aDrug Interactions
650 0 4 _aHumans
650 0 4 _aHypotension, Orthostatic
_xblood
650 0 4 _aImipramine
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOlanzapine
650 0 4 _aPirenzepine
_xadverse effects
650 0 4 _aPsychomotor Performance
_xdrug effects
650 0 4 _aSingle-Blind Method
700 1 _aCerimele, B J
700 1 _aKassahun, K J
700 1 _aNyhart, E H
700 1 _aHoyes-Beehler, P J
700 1 _aKondraske, G V
773 0 _tJournal of clinical pharmacology
_gvol. 37
_gno. 10
_gp. 971-8
856 4 0 _uhttps://doi.org/10.1002/j.1552-4604.1997.tb04272.x
_zAvailable from publisher's website
999 _c9473823
_d9473823